Inventor profile of:

Matthew BAKER

City:

Cambridge

Country:

United Kingdom

Published Applications:

29

Last publication date:

2024-12-26

Top Assignees for applications by Matthew BAKER

The entities that hold a legal rights for patent applications filed by inventor BAKER Matthew:

Recent patent applications by BAKER Matthew

Matthew BAKER from Cambridge, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-12-26
US20240430024A1
Electricity

IMPROVEMENT OF LINEAR BEAM SWEEPING IN HIGH SPEED SCENARIOS

#2 | 2024-08-29
US20240291613A1
Electricity

SYNCHRONIZATION RASTER BASED INDICATION OF NARROWBAND SYSTEM INFORMATION MODIFICATIONS

#3 | 2023-03-02
US20230060839A1
Electricity

DOWNLINK SIZE ESTIMATION FOR MULTICAST TRAFFIC

#4 | 2022-11-17
US20220368412A1
Electricity

Frequency control

#5 | 2022-09-15
US20220294541A1
Electricity

Total radiated power measurements of in-band channel frequencies based on beam directivity

#6 | 2022-02-10
US20220046724A1
Electricity

Methods for UL RACH coverage extension

#7 | 2021-12-23
US20210400640A1
Electricity

COMMUNICATIONS WITH PRECONFIGURED UPLINK RESOURCES

#8 | 2021-12-09
US20210385017A1
Electricity

Apparatus, method and computer program

#9 | 2021-10-07
US20210314851A1
Electricity

Method for standalone MTC operation

#10 | 2021-03-04
US20210068065A1
Electricity

Method and signaling for optimized cell switch in earth fixed cells NTN configuration

#11 | 2020-11-19
US20200367199A1
Electricity

Using wake up signal to skip paging DCI

#12 | 2019-09-19
US20190285721A1
Physics

Position detection of user equipment within a wireless telecommunications network

#13 | 2015-01-15
US20150018526A1
Chemistry; metallurgy

Cytotoxins comprising modified bouganin toxin for the treatment of cancer

#14 | 2010-10-07
US20100254964A1
Chemistry; metallurgy

Cytotoxins comprising modified bouganin toxin for the treatment of cancer

#15 | 2009-09-10
US20090226893A1
Human necessities

Methods of studying tolerance in MHC-II transgenic animals

#16 | 2009-09-03
US20090221024A1
Physics

T CELL ASSAYS

#17 | 2009-04-28
US10495146
-

Modified anti-TNF alpha antibody

#18 | 2008-09-11
US20080219994A1
Chemistry; metallurgy

Modified bouganin proteins, cytotoxins and methods and uses thereof

#19 | 2007-12-06
US20070281316A1
Chemistry; metallurgy

Inhibiting denaturation of nucleic acid duplexes

#20 | 2006-07-20
US20060160995A1
Chemistry; metallurgy

Thrombopoietin proteins with improved properties

#21 | 2006-06-29
US20060140929A1
Chemistry; metallurgy

Modified hirudin proteins and T-cell epitopes in hirudin

#22 | 2006-03-23
US20060062761A1
Chemistry; metallurgy

Modified interferon alpha with reduced immunogenicity

#23 | 2006-01-26
US20060019885A1
Chemistry; metallurgy

Modified bryodin 1 with reduced immunogenicity

#24 | 2006-01-26
US20060018903A1
Chemistry; metallurgy

TNF alpha-binding polypeptide compositions and methods

#25 | 2005-11-17
US20050256304A1
Chemistry; metallurgy

Modified factor VIII

#26 | 2005-10-27
US20050238642A1
Chemistry; metallurgy

Modified bouganin proteins, cytotoxins and methods and uses thereof

#27 | 2005-10-06
US20050221307A1
Chemistry; metallurgy

Stabilisation of double-stranded nucleic acids using proteins

#28 | 2005-08-18
US20050181459A1
Physics

Method for mapping and eliminating T cell epitopes

#29 | 2005-04-07
US20050074863A1
Chemistry; metallurgy

T-cell epitodes in carboxypeptidase g2

InventorID:

1037755 ⎘